Fosun Health Capital
Profile, fund size and portfolio
Fosun Health Capital is the corporate venture arm of Fosun Pharma, a pharmaceutical and biotech company. It was founded in 2020 and is based in Shanghai, China. It invests from pre-seed to seed. Sectors it names: healthcare and digital health.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Pre-seed to Seed |
| Sectors | Healthcare and digital health |
| Geography | Asia |
| Offices | Shanghai, China |
Sources: S1 Fosun Pharma: Fosun Pharma explores linked investment and incubation (Securities Daily).
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | CNY 1.5bn | Fund size | Stated by the firm or its parent | S1 |
| Companies backed | 10 | companies | Stated by the firm | S1 |
| Companies on the firm's portfolio page | 10 | companies | Counted from the firm's own list | S1 |
Sources: S1 Fosun Pharma: Fosun Pharma explores linked investment and incubation (Securities Daily).
Where it invests and who leads it
LeadersS1S2
- 崔志平Joint CEO of Fosun Health Capital and General Manager of the New Drug Innovation Fund (复健资本联席CEO、新药创新基金总经理)Find on LinkedInFirm page
- 刘晓华Managing Director (董事总经理)Find on LinkedInFirm page
- 宋怀恩Managing Director (董事总经理)Find on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Fosun Pharma | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Founded | 2020 | Single source | S1 |
| Headquarters | Shanghai, China | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent and outside investors | Single source | S1 |
| Headline size | CNY 1.5bn (Fund size) | Single source | S1 |
| Companies backed | 10 | Single source | S1 |
| Stages | Pre-seed, Seed | Single source | S1 |
For founders
| Item | What the firm says | Source |
|---|---|---|
| Stages | Pre-seed, Seed | S1 |
Fund vehicles
| Vehicle | Size | Year | Source |
|---|---|---|---|
| Fosun Health Capital New Drug Innovation Fund | CNY 1.5bn | 2020 | S1 |
Portfolio
The firm's portfolio page lists 10 companies.S1
Every company on the Fosun Health Capital list
10 companies, as listed on the firm's own website.S1 Read the firm's list.
- 博奥明赛
- 星丝奕
- 星奥拓维
- 星明优健
- 星曜坤泽
- 星核迪赛
- 星济生物
- 星联肽
- 星赛瑞真
- 星魅生物
History
- New Drug Innovation Fund founded in August 2020 (RMB 1.5 billion; final close February 2021)S1
- Incubated Xingji Biotech (2020-06), Raziel RZL012 license via Tianjin Xingmei (2020-09)S3
- Incubated stem cell regenerative medicine company 星赛瑞真 (2022-07), mRNA company 星核迪赛 (2022-06) and gene therapy company 星奥拓维 (2022-01)S3
Official pages
Read the firm's own pages for current information.
- Website www.fosunhealthcapital.com/
Sources
- S1Fosun Pharma: Fosun Pharma explores linked investment and incubation (Securities Daily)Firm
- S2Fosun Health Capital site: management team pageFirm
- S3Fosun Health Capital site: invested projects pageFirm
- S4VBData (Dongmai Wang): interview with Cui Zhiping of Fosun Health Capital New Drug Innovation FundPress
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Fosun Health Capital or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.